3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Pain
4
Pain, Postoperative
3
Agnosia
3
Ovarian Neoplasms
2
Inflammation
2
Fallopian Tube Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Thyroid Nodule
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Obesity
1
Neoplasms
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma, Follicular
1
Lymphoma
1
Liver Neoplasms
1
Liver Diseases
1
Kidney Neoplasms
1
Ileus
1
Goiter
1
Emergencies
1
Diverticulosis, Colonic
1
Diverticulitis, Colonic
1
Curative Breast Cancer Surgery
1
Constipation
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Chronic Pain
1
Interventions
Exercise
24
Metformin
23
Resistance Training
8
Nutrition Assessment
8
Methods
8
Tirzepatide
7
Diet Therapy
7
Diet
7
Counseling
7
Early Intervention, Educational
6
Caloric Restriction
6
Exenatide
5
semaglutide
4
Liraglutide
4
Educational Status
4
Docosahexaenoic Acids
4
Diet, Mediterranean
4
Vitamin D
3
Therapeutics
3
Surveys and Questionnaires
3
Sugars
3
Standard of Care
3
Dexamethasone
3
Yoga
2
Tablets
2
Specimen Handling
2
Progestins
2
Ovidrel
2
Nutritional Status
2
Naltrexone
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Obesity
×
Ketorolac
×
Clear all
NCT06150898
2025-06-13
KePreSt
Jules Bordet Institute
Phase 2
Recruiting
112 enrolled